These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35685506)

  • 1. Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis.
    Chen M; Liu J; Xiong Y; Xu G
    Int J Clin Pract; 2022; 2022():4996239. PubMed ID: 35685506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
    Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
    Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study.
    Chen X; Jiao S; Li S; Li J; Li P; Song F; Yan Z
    Balkan Med J; 2023 Jul; 40(4):287-293. PubMed ID: 37260416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis.
    Dai P; Xie W; Yu X; Sun J; Wang S; Kawuki J
    Int Immunopharmacol; 2021 May; 94():107376. PubMed ID: 33582591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
    Peng L; Wei SY; Li LT; He YX; Li B
    J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
    Lu W; Gong S; Li J; Luo H; Wang Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials.
    Tian Z; Li Y; Xie Y; Yang Y; Xu J
    Int Urol Nephrol; 2022 Oct; 54(10):2555-2566. PubMed ID: 35277831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis.
    Liu J; Li X; Huang T; Xu G
    Front Pharmacol; 2022; 13():917532. PubMed ID: 35959430
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for the treatment of idiopathic membranous nephropathy with nephrotic syndrome: a systematic review and meta-analysis.
    You L; Ye P; Xiao G; Liang J; Kong Y
    Turk J Med Sci; 2021 Dec; 51(6):2870-2880. PubMed ID: 34391323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis.
    Yang P; Wang Q; Xie C; Xu G; Wu Q
    Kidney Blood Press Res; 2018; 43(6):1890-1897. PubMed ID: 30566932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC
    J Nephrol; 2022 May; 35(4):1159-1170. PubMed ID: 35199314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
    J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Dec; 100(51):e28225. PubMed ID: 34941086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.